loadpatents
Patent applications and USPTO patent grants for Bonnafous; Ludovic.The latest application filed is for "dual-action elafibranor metformin salt for treating obesity associated with non-alcoholic steatohepatitis (nash) and hypertrigly".
Patent | Date |
---|---|
Composition comprising at least one water-soluble pharmaceutically acceptable salt of elafibranor having improved intestinal absorption Grant 11,185,520 - Laruelle , et al. November 30, 2 | 2021-11-30 |
Dual-action Elafibranor Metformin Salt For Treating Obesity Associated With Non-alcoholic Steatohepatitis (nash) And Hypertrigly App 20200023067 - LARUELLE; Claude ;   et al. | 2020-01-23 |
Composition Comprising At Least One Water-soluble Pharmaceutically Acceptable Salt Of Elafibranor Having Improved Intestinal Abs App 20190274982 - LARUELLE; Claude ;   et al. | 2019-09-12 |
Use Of Fenofibric Acid In The Treatment Of Hepatic Diseases App 20190247343 - LARUELLE; Claude ;   et al. | 2019-08-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.